Articles Referencing JNJ

Making Money Alert: The Fed Keeps Feeding the Bull
5/23/2013, 5:27 pm from Eagle Financial Publications in Investing, Economy, Stocks, US Markets
By Doug Fabian It’s often said that the key to a successful business is to provide customers what they want. Well, perhaps that’s the mindset of Federal Reserve Chairman Ben Bernanke, as he... Read >>

Alkermes Reports Earnings for Q4 - Analyst Blog
5/23/2013, 2:07 pm from Zacks.com in Investing, Business, Earnings, Stocks
Alkermes plc 's ( ALKS ) fourth quarter
of fiscal 2013 (ended Mar 31, 2013) adjusted earnings (including
stock-based compensation expense) of 21 cents per share compared
favorably to the... Read >>

Workday's Loss Narrows in 1Q - Analyst Blog
5/23/2013, 9:29 am from Zacks.com in Investing, Business, Stocks
Enterprise cloud applications provider for human resource and
finance, Workday Inc. ( WDAY ) reported first-quarter 2014 loss per share of 15
cents, considerably narrower than loss per... Read >>

New Stock Coverage: Can Johnson & Johnson Be Market's Band-Aid?
5/23/2013, 9:25 am from Minyanville in Investing, Stocks
Ben Bernanke, clearly no Keynesian , recently delivered a speech
entitled " Economic Prospects for the Long Run. " What,
then, would he make of the extremely short-term stock... Read >>

Gilead's Sofosbuvir under European Review - Analyst Blog
5/22/2013, 4:27 pm from Zacks.com in Investing, Business, Stocks
Gilead Sciences Inc. ( GILD ) recently
announced that its Marketing Authorisation Application (MAA) for
HCV candidate sofosbuvir (formerly GS-7977), submitted to the
European Medicines... Read >>

Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 23, 2013
5/22/2013, 9:00 am from NASDAQ.com News in News Headlines, Stocks
Johnson & Johnson ( JNJ ) will begin
trading ex-dividend on May 23, 2013. A cash dividend payment of
$0.66 per share is scheduled to be paid on June 11, 2013.
Shareholders who purchased... Read >>

JNJ's Simponi Label Expanded - Analyst Blog
5/21/2013, 11:26 am from Zacks.com in Investing, Business, Stocks
Johnson & Johnson's ( JNJ ) recently gained
approval from the US Food and Drug Administration (FDA) for the
expansion of Simponi's label. The FDA granted Simponi approval for
the... Read >>

Allergan, Inc. (AGN) Ex-Dividend Date Scheduled for May 21, 2013
5/20/2013, 9:00 am from NASDAQ.com News in News Headlines, Stocks
Allergan, Inc. ( AGN ) will begin
trading ex-dividend on May 21, 2013. A cash dividend payment of
$0.05 per share is scheduled to be paid on June 13, 2013.
Shareholders who purchased AGN stock... Read >>

Small Is Beautiful: Now's the Time for Growth-Oriented Investors to Move Into Small-Cap Stocks
5/17/2013, 10:22 am from Minyanville in Investing, Stocks
I like -- no, love -- large multi-national dividend-paying
stocks. If you read my musings, you will notice it's a theme I
return to over and over again.
But these large-caps can be sleepy... Read >>

Some Dividend ETFs Outperforming The S&P 500
5/16/2013, 5:46 pm from Investor's Business Daily in Personal Finance, Investing Ideas
So much for stodgy, slow-moving dividend stocks. Of nearly 50 dividend-focused exchange traded funds, 18 are
outperforming the S&P 500 this year. TheSPDR S&P Dividend ( SDY ... Read >>

X Factor: 5 Stocks Reaching Their Ex-Dividend Date on May 23
5/16/2013, 9:38 am from Minyanville in Investing, Stocks
Many stocks will reach their ex-dividend date next Thursday,
which is significant for investors as the seller of the stock on
that date, not the buyer, receives the most recent dividend.
A ... Read >>

George Soros Buys Google, Liberty Global, Sells Citigroup, AIG, GE, Apple
5/16/2013, 9:26 am from GuruFocus in Investing
George Soros just reported his first quarter
portfolio. He seems to be bullish as he has bought more stocks than
sold. He added to his positions in Google, Liberty Global, etc.,
bought into... Read >>

LabStyle Innovations - Glucose Monitoring For The Mobile Age
5/15/2013, 12:24 pm from SeekingAlpha in Investing, Technology
By Jason
Napodano : Today, Zacks initiated coverage of LabStyle Innovations Corp.
(DRIO.OB) with a Buy rating. LabStyle is a healthcare technology
company that has developed an... Read >>

Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for May 16, 2013
5/15/2013, 9:00 am from NASDAQ.com News in News Headlines, Stocks
Teva Pharmaceutical Industries Limited ( TEVA ) will begin
trading ex-dividend on May 16, 2013. A cash dividend payment of
$0.32 per share is scheduled to be paid on June 03, 2013.
Shareholders... Read >>

Nature's Sunshine Products, Inc. (NATR) Ex-Dividend Date Scheduled for May 16, 2013
5/15/2013, 9:00 am from NASDAQ.com News in News Headlines, Stocks
Nature's Sunshine Products, Inc. ( NATR ) will begin
trading ex-dividend on May 16, 2013. A cash dividend payment of
$0.1 per share is scheduled to be paid on May 30, 2013.
Shareholders who... Read >>